Latest On Millendo Therapeutics, Inc (MLND):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-03-29 14:16 EST | News | Millendo stock slumps on merger deal with Tempest Therapeutics | N/A |  |
| 2021-01-29 03:30 EST | News | Millendo discloses restructuring plan to cut up to 85% of its workforce | N/A | |
| 2021-01-07 08:09 EST | Analyst Rating | The Analyst Target Price has decreased from $3 to $2. | Neutral | |
| 2021-01-06 16:11 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-06 08:10 EST | Analyst Rating | The Analyst Target Price has decreased from $4 to $3. | Neutral | |
| 2021-01-05 17:52 EST | News | Millendo Therapeutics shares drop after pulling plug on MLE-301 development | N/A | |
| 2020-11-26 20:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 20:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 12:34 EST | Earnings Estimate | An EPS average of -$0.45 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-10 12:34 EST | Analyst Rating | The Analyst Target Price has decreased from $4.33 to $4. | Neutral | |
| 2020-11-09 13:52 EST | News | Millendo Therapeutics EPS beats by $0.12 | N/A | |
| 2020-11-07 16:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 13:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-24 18:51 EST | News | Millendo launches early-stage study of lead drug | N/A | |
| 2020-09-17 05:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-01 21:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-29 21:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-26 05:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-22 17:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-19 09:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 09:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 13:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 17:13 EST | News | Millendo Therapeutics EPS misses by $0.01 | N/A | |
| 2020-07-31 01:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-07 17:11 EST | Analyst Rating | The Analyst Target Price has decreased from $4.8 to $4.33. | Neutral | |
| 2020-07-01 17:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-26 09:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-24 11:20 EST | News | Millendo under pressure after bailing on nevanimibe | N/A | |
| 2020-06-16 05:07 EST | Analyst Rating | The Analyst Target Price has increased from $4.33 to $4.8. | Buy | |
| 2020-06-15 01:10 EST | Analyst Rating | The Analyst Target Price has decreased from $4.57 to $4.33. | Neutral | |
| 2020-06-12 05:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-02 17:21 EST | Analyst Rating | The Analyst Target Price has increased from $4.5 to $4.57. | Buy | |
| 2020-06-02 17:21 EST | Earnings Estimate | An EPS average of -$0.51 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-05-27 05:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-10 01:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-09 12:23 EST | News | Millendo Therapeutics EPS beats by $0.02 | N/A | |
| 2020-05-06 05:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 05:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-12 02:13 EST | News | Millendo Therapeutics EPS misses by $0.06 | N/A | |
| 2020-04-12 01:43 EST | News | Millendo Therapeutics' livoletide flunks study; shares crater 69% premarket | N/A | |
| 2020-04-09 13:04 EST | Analyst Rating | The Analyst Target Price has decreased from $13.17 to $4.5. | Neutral | |
| 2020-04-08 01:11 EST | Analyst Rating | The Analyst Target Price has decreased from $26.67 to $13.17. | Neutral | |
| 2020-04-06 05:01 EST | Analyst Rating | The Analyst Target Price has increased from $25.71 to $26.67. | Buy | |
| 2020-04-03 01:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-02 05:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-31 01:09 EST | Analyst Rating | The Analyst Target Price has decreased from $26.14 to $25.71. | Neutral | |
| 2020-03-13 05:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-12 05:03 EST | Earnings Estimate | An EPS average of -$0.67 is estimated for the quarter ending on June 30, 2020. | Buy | |
About Millendo Therapeutics, Inc (MLND):
Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.
General
- Name Millendo Therapeutics, Inc
- Symbol MLND
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 24
- Last Split Factor1:15
- Last Split Date2018-12-10
- Fiscal Year EndDecember
- IPO Date2012-11-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.millendo.com
View More
Valuation
- Price/Book (Most Recent Quarter) 1.03
- Enterprise Value EBITDA 0.07
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.46
- Return on Assets -48%
- Return on Equity -99%
- Earnings Per Share -$4.87
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 43.13 million
- EBITDA -34481000
- Analyst Target Price $2
- Book Value Per Share $2.06
View More
Share Statistics
- Shares Outstanding 19 million
- Shares Float 16.04 million
- % Held by Insiders 629%
- % Held by Institutions 41.79%
- Shares Short 313021
- Shares Short Prior Month 436722
- Short Ratio 0.45
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 0.63
- 52 Week High $7.02
- 52 Week Low $1.3
- 50 Day Moving Average 2.23
- 200 Day Moving Average 1.87
View More
Dividends
- Dividend Date 2018-12-10
- ExDividend Date N/A
- Dividend Yield 0%
View More
Millendo Therapeutics, Inc (MLND) Dividend Calendar:
MLND's last dividend payment was made to shareholders on December 10, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Millendo Therapeutics, Inc (MLND) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-09 | $N/A | -$0.34 | -$0.46 | 26.09% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.56 | -$0.55 | -2.43% |
| 2020-03-31 | 2020-05-08 | $N/A | -$0.65 | -$0.67 | 2.5% |
| 2019-12-31 | 2020-03-11 | $N/A | -$0.87 | -$0.81 | -7.25% |
| 2019-09-30 | 2019-11-13 | $N/A | -$0.87 | -$0.83 | -5.33% |
| 2019-06-30 | 2019-08-12 | $N/A | -$0.74 | -$0.81 | 8.42% |
| 2019-03-31 | 2019-05-15 | $N/A | -$0.78 | -$0.70 | -10.91% |
| 2018-12-31 | 2019-03-29 | $N/A | -$0.82 | -$0.86 | 4.65% |
| 2018-09-30 | 2018-11-09 | $55000 | -$2.38 | ||
| 2018-06-30 | 2018-08-09 | $81000 | -$3.23 | ||
| 2018-03-31 | 2018-05-03 | $67000 | -$3.09 | ||
| 2017-12-31 | 2018-03-15 | $155000 | -$3.60 | -$4.13 | 12.83% |
| 2017-09-30 | 2017-11-02 | $56000 | -$3.90 | -$5.98 | 34.78% |
| 2017-06-30 | 2017-08-03 | $84000 | -$7.65 | -$6.29 | -21.62% |
| 2017-03-31 | 2017-05-09 | -$6.30 | -$6.40 | 1.56% | |
| 2016-12-31 | 2017-03-02 | $121000 | -$7.35 | -$8.66 | 15.13% |
| 2016-09-30 | 2016-11-03 | $197000 | -$0.54 | -$0.61 | 11.48% |
| 2016-06-30 | 2016-08-04 | $189000 | -$0.62 | -$0.78 | 20.51% |
| 2016-03-31 | 2016-05-05 | $146000 | -$0.80 | -$0.72 | -11.11% |
| 2015-12-31 | 2016-02-25 | $157000 | -$0.76 | -$0.70 | -8.57% |
| 2015-09-30 | 2015-11-05 | $75000 | -$0.66 | -$0.67 | 1.49% |
| 2015-06-30 | 2015-08-10 | $30000 | -$0.64 | -$0.64 | 0% |
| 2015-03-31 | 2015-05-11 | $15000 | -$0.65 | -$0.70 | 7.14% |
| 2014-12-31 | 2015-03-16 | -$0.79 | -$0.59 | -33.9% | |
| 2014-09-30 | 2014-11-10 | $N/A | -$0.54 | -$0.45 | -20% |
| 2014-06-30 | 2014-08-07 | $N/A | -$6.30 | -$6.77 | 6.94% |
| 2014-03-31 | 2014-05-08 | $N/A | -$6.15 | -$6.95 | 11.51% |
| 2013-12-31 | 2014-02-27 | -$5.40 | -$5.90 | 8.47% | |
| 2013-09-30 | 2013-11-13 | $N/A | -$6.00 | -$5.17 | -16.05% |
| 2013-06-30 | 2013-08-13 | $N/A | -$5.40 | -$4.12 | -31.07% |
| 2013-03-31 | 2013-05-15 | $N/A | -$5.85 | -$4.12 | -41.99% |
| 2012-12-31 | 2013-02-25 | -$4.95 | -$4.35 | -13.79% | |
| 2012-09-30 | 2012-11-28 | $N/A | -$6.29 |
Millendo Therapeutics, Inc (MLND) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Millendo Therapeutics, Inc (MLND) Chart:
Millendo Therapeutics, Inc (MLND) News:
Below you will find a list of latest news for Millendo Therapeutics, Inc (MLND) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Millendo Therapeutics, Inc (MLND) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Millendo Therapeutics, Inc (MLND) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465920075873/0001104659-20-075873-index.htm |
| 2019-04-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1544227/000000000019007092/0000000000-19-007092-index.htm |
| 2019-02-01 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000005341719000055/0000053417-19-000055-index.htm |
| 2018-12-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000093041318003561/0000930413-18-003561-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000093041319000569/0000930413-19-000569-index.htm |
| 2018-12-20 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1544227/000104746918007756/0001047469-18-007756-index.htm |
| 2019-04-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1544227/000104746919002022/0001047469-19-002022-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1544227/000104746919002693/0001047469-19-002693-index.htm |
| 2019-12-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1544227/000104746919006634/0001047469-19-006634-index.htm |
| 2019-12-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1544227/000104746919006670/0001047469-19-006670-index.htm |
| 2020-03-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1544227/000104746920001193/0001047469-20-001193-index.htm |
| 2018-12-18 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1544227/000107261318000563/0001072613-18-000563-index.htm |
| 2018-12-13 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1544227/000110465918072717/0001104659-18-072717-index.htm |
| 2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465918072810/0001104659-18-072810-index.htm |
| 2018-12-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000110465918073347/0001104659-18-073347-index.htm |
| 2018-12-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000110465918073351/0001104659-18-073351-index.htm |
| 2018-12-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000110465918073366/0001104659-18-073366-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919001011/0001104659-19-001011-index.htm |
| 2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919002767/0001104659-19-002767-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919006384/0001104659-19-006384-index.htm |
| 2019-04-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1544227/000110465919020207/0001104659-19-020207-index.htm |
| 2019-04-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1544227/000110465919021695/0001104659-19-021695-index.htm |
| 2019-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919021957/0001104659-19-021957-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1544227/000110465919024589/0001104659-19-024589-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919035378/0001104659-19-035378-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919036064/0001104659-19-036064-index.htm |
| 2019-12-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919070199/0001104659-19-070199-index.htm |
| 2019-12-16 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1544227/000110465919072796/0001104659-19-072796-index.htm |
| 2019-12-16 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1544227/000110465919072949/0001104659-19-072949-index.htm |
| 2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465919074096/0001104659-19-074096-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465920003161/0001104659-20-003161-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465920012871/0001104659-20-012871-index.htm |
| 2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465920028925/0001104659-20-028925-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465920043387/0001104659-20-043387-index.htm |
| 2020-06-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000110465920075873/0001104659-20-075873-index.htm |
| 2020-07-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1544227/000110465920088216/0001104659-20-088216-index.htm |
| 2019-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000113777419000049/0001137774-19-000049-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000117266120000845/0001172661-20-000845-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000119312519039500/0001193125-19-039500-index.htm |
| 2020-04-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000119312520101340/0001193125-20-101340-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062092/0001209191-18-062092-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062094/0001209191-18-062094-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062095/0001209191-18-062095-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062096/0001209191-18-062096-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062097/0001209191-18-062097-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062098/0001209191-18-062098-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062100/0001209191-18-062100-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062103/0001209191-18-062103-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062104/0001209191-18-062104-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062105/0001209191-18-062105-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062106/0001209191-18-062106-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062107/0001209191-18-062107-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062108/0001209191-18-062108-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062111/0001209191-18-062111-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062113/0001209191-18-062113-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062116/0001209191-18-062116-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062117/0001209191-18-062117-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062119/0001209191-18-062119-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062120/0001209191-18-062120-index.htm |
| 2018-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062123/0001209191-18-062123-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062124/0001209191-18-062124-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062125/0001209191-18-062125-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062126/0001209191-18-062126-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062127/0001209191-18-062127-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004226/0001209191-19-004226-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004228/0001209191-19-004228-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004231/0001209191-19-004231-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004235/0001209191-19-004235-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004237/0001209191-19-004237-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004239/0001209191-19-004239-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004241/0001209191-19-004241-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004242/0001209191-19-004242-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004243/0001209191-19-004243-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004245/0001209191-19-004245-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119004246/0001209191-19-004246-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038475/0001209191-19-038475-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038478/0001209191-19-038478-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038479/0001209191-19-038479-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038481/0001209191-19-038481-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038482/0001209191-19-038482-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038485/0001209191-19-038485-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038486/0001209191-19-038486-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038488/0001209191-19-038488-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119038489/0001209191-19-038489-index.htm |
| 2019-08-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119046914/0001209191-19-046914-index.htm |
| 2019-08-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119046915/0001209191-19-046915-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119046917/0001209191-19-046917-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119046918/0001209191-19-046918-index.htm |
| 2019-12-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119061354/0001209191-19-061354-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919119061358/0001209191-19-061358-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120006345/0001209191-20-006345-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120006355/0001209191-20-006355-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120006361/0001209191-20-006361-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120006367/0001209191-20-006367-index.htm |
| 2020-02-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120008367/0001209191-20-008367-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120008370/0001209191-20-008370-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120021851/0001209191-20-021851-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120032485/0001209191-20-032485-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120032486/0001209191-20-032486-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120032487/0001209191-20-032487-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120032488/0001209191-20-032488-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000120919120032489/0001209191-20-032489-index.htm |
| 2019-02-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000138713119001297/0001387131-19-001297-index.htm |
| 2020-03-17 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000138713120002923/0001387131-20-002923-index.htm |
| 2020-03-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000004/0001544227-20-000004-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000008/0001544227-20-000008-index.htm |
| 2020-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000010/0001544227-20-000010-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000014/0001544227-20-000014-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000029/0001544227-20-000029-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000030/0001544227-20-000030-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000031/0001544227-20-000031-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000032/0001544227-20-000032-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000033/0001544227-20-000033-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000034/0001544227-20-000034-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000035/0001544227-20-000035-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000039/0001544227-20-000039-index.htm |
| 2020-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000154422720000042/0001544227-20-000042-index.htm |
| 2019-03-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000155837019002387/0001558370-19-002387-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1544227/000155837019002584/0001558370-19-002584-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1544227/000155837019002660/0001558370-19-002660-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1544227/000155837019005038/0001558370-19-005038-index.htm |
| 2019-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1544227/000155837019007932/0001558370-19-007932-index.htm |
| 2019-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1544227/000155837019010887/0001558370-19-010887-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1544227/000156761919002498/0001567619-19-002498-index.htm |
| 2019-04-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1544227/999999999519000760/9999999995-19-000760-index.htm |
Millendo Therapeutics, Inc (MLND) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Millendo Therapeutics, Inc (MLND). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 629%Institutional Ownership: 4179%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-07 | RANDALL W WHITCOMB | Director | Buy | 15,784.00 | 15,784.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062127/0001209191-18-062127-index.htm | ||
| 2018-12-07 | Carol Giltner Gallagher | Director | Buy | 23,684.00 | 23,684.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062111/0001209191-18-062111-index.htm | ||
| 2018-12-07 | MARY FISHER | Director | Buy | 355.00 | 3,319.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062108/0001209191-18-062108-index.htm | ||
| 2018-12-07 | RICHARD ALDRICH | Director | Buy | 755.00 | 6,169.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062104/0001209191-18-062104-index.htm | ||
| 2018-12-07 | Pharis Mohideen | Chief Medical Officer | Buy | 7,440.00 | 7,440.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062125/0001209191-18-062125-index.htm | ||
| 2018-12-07 | Julia C. Owens | President and CEO | Buy | 74,400.00 | 74,400.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062126/0001209191-18-062126-index.htm | ||
| 2018-12-07 | MARC D KOZIN | Director | Buy | 831.00 | 7,740.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062119/0001209191-18-062119-index.htm | ||
| 2018-12-07 | Carol Giltner Gallagher | Director | Buy | 8,249.00 | 8,249.00 | https://www.sec.gov/Archives/edgar/data/1544227/000120919118062111/0001209191-18-062111-index.htm |